N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide

C99H97N35O5S5 — CID 158038804

IUPACN-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide
SMILESCC(=O)Nc1ccc(Sc2cc3cnc(C)n3c(Nc3cc(C)[nH]n3)n2)cc1.CC(=O)Nc1ccc(Sc2cc3cncn3c(Nc3cc(C)[nH]n3)n2)cc1.Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)cc3cnc(C)n23)n[nH]1.Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)cc3cncn23)n[nH]1.Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)cn3c(C)cnc23)n[nH]1
InChIInChI=1S/2C21H21N7OS.C20H19N7OS.C19H19N7OS.C18H17N7OS/c1-12-9-18(27-26-12)24-21-25-19(10-16-11-22-13(2)28(16)21)30-17-7-5-15(6-8-17)23-20(29)14-3-4-14;1-12-9-17(27-26-12)24-19-20-22-10-13(2)28(20)11-18(25-19)30-16-7-5-15(6-8-16)23-21(29)14-3-4-14;1-12-8-17(26-25-12)23-20-24-18(9-15-10-21-11-27(15)20)29-16-6-4-14(5-7-16)22-19(28)13-2-3-13;1-11-8-17(25-24-11)22-19-23-18(9-15-10-20-12(2)26(15)19)28-16-6-4-14(5-7-16)21-13(3)27;1-11-7-16(24-23-11)21-18-22-17(8-14-9-19-10-25(14)18)27-15-5-3-13(4-6-15)20-12(2)26/h2*5-11,14H,3-4H2,1-2H3,(H,23,29)(H2,24,25,26,27);4-11,13H,2-3H2,1H3,(H,22,28)(H2,23,24,25,26);4-10H,1-3H3,(H,21,27)(H2,22,23,24,25);3-10H,1-2H3,(H,20,26)(H2,21,22,23,24)
InChIKeyFICCFLYRBWNOMK-UHFFFAOYSA-N
MW2017.44 g/mol
LogP20.17
Rot. Bonds28

About N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide

N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide (PubChem CID 158038804) has the molecular formula C99H97N35O5S5 and a molecular weight of 2017.44 g/mol. Its IUPAC name is N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide.

Molecular Properties

Compound NameN-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide
PubChem CID158038804
Molecular FormulaC99H97N35O5S5
Molecular Weight2017.44 g/mol
Exact Mass2015.70
IUPAC NameN-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide
SMILESCC(=O)Nc1ccc(Sc2cc3cnc(C)n3c(Nc3cc(C)[nH]n3)n2)cc1.CC(=O)Nc1ccc(Sc2cc3cncn3c(Nc3cc(C)[nH]n3)n2)cc1.Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)cc3cnc(C)n23)n[nH]1.Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)cc3cncn23)n[nH]1.Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)cn3c(C)cnc23)n[nH]1
InChIInChI=1S/2C21H21N7OS.C20H19N7OS.C19H19N7OS.C18H17N7OS/c1-12-9-18(27-26-12)24-21-25-19(10-16-11-22-13(2)28(16)21)30-17-7-5-15(6-8-17)23-20(29)14-3-4-14;1-12-9-17(27-26-12)24-19-20-22-10-13(2)28(20)11-18(25-19)30-16-7-5-15(6-8-16)23-21(29)14-3-4-14;1-12-8-17(26-25-12)23-20-24-18(9-15-10-21-11-27(15)20)29-16-6-4-14(5-7-16)22-19(28)13-2-3-13;1-11-8-17(25-24-11)22-19-23-18(9-15-10-20-12(2)26(15)19)28-16-6-4-14(5-7-16)21-13(3)27;1-11-7-16(24-23-11)21-18-22-17(8-14-9-19-10-25(14)18)27-15-5-3-13(4-6-15)20-12(2)26/h2*5-11,14H,3-4H2,1-2H3,(H,23,29)(H2,24,25,26,27);4-11,13H,2-3H2,1H3,(H,22,28)(H2,23,24,25,26);4-10H,1-3H3,(H,21,27)(H2,22,23,24,25);3-10H,1-2H3,(H,20,26)(H2,21,22,23,24)
InChIKeyFICCFLYRBWNOMK-UHFFFAOYSA-N
XLogP20.17
TPSA500.00 Ų
H-Bond Donors15
H-Bond Acceptors35
Rotatable Bonds28
Heavy Atoms144
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002017.44
LogP ≤ 520.17
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1035

Analyze N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide?
The IUPAC name of N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide (CID 158038804) is N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide.
What is the SMILES notation for N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide?
The canonical SMILES for N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide is CC(=O)Nc1ccc(Sc2cc3cnc(C)n3c(Nc3cc(C)[nH]n3)n2)cc1.CC(=O)Nc1ccc(Sc2cc3cncn3c(Nc3cc(C)[nH]n3)n2)cc1.Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)cc3cnc(C)n23)n[nH]1.Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)cc3cncn23)n[nH]1.Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)cn3c(C)cnc23)n[nH]1.
What is the InChIKey of N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide?
The InChIKey is FICCFLYRBWNOMK-UHFFFAOYSA-N. The full InChI is InChI=1S/2C21H21N7OS.C20H19N7OS.C19H19N7OS.C18H17N7OS/c1-12-9-18(27-26-12)24-21-25-19(10-16-11-22-13(2)28(16)21)30-17-7-5-15(6-8-17)23-20(29)14-3-4-14;1-12-9-17(27-26-12)24-19-20-22-10-13(2)28(20)11-18(25-19)30-16-7-5-15(6-8-16)23-21(29)14-3-4-14;1-12-8-17(26-25-12)23-20-24-18(9-15-10-21-11-27(15)20)29-16-6-4-14(5-7-16)22-19(28)13-2-3-13;1-11-8-17(25-24-11)22-19-23-18(9-15-10-20-12(2)26(15)19)28-16-6-4-14(5-7-16)21-13(3)27;1-11-7-16(24-23-11)21-18-22-17(8-14-9-19-10-25(14)18)27-15-5-3-13(4-6-15)20-12(2)26/h2*5-11,14H,3-4H2,1-2H3,(H,23,29)(H2,24,25,26,27);4-11,13H,2-3H2,1H3,(H,22,28)(H2,23,24,25,26);4-10H,1-3H3,(H,21,27)(H2,22,23,24,25);3-10H,1-2H3,(H,20,26)(H2,21,22,23,24).
What are the key properties of N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide?
N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide has a molecular weight of 2017.44 g/mol, XLogP of 20.17, 28 rotatable bonds, 15 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[3-methyl-8-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,2-a]pyrazin-6-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[3-methyl-5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]acetamide;N-[4-[5-[(5-methyl-1H-pyrazol-3-yl)amino]imidazo[1,5-c]pyrimidin-7-yl]sulfanylphenyl]cyclopropanecarboxamide is sourced from PubChem (CID 158038804), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).